Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Closed Posted

Opportunity number
PAR-24-280
Agency
Applications due
Award size
Not on record

Opportunity facts

Funding instrument
Grant
Category
  • Health
Eligible applicants
  • City/Township Governments
  • Tribal Organizations (Not Federally Recognized)
  • Non-501(c)(3) Nonprofits
  • County Governments
  • Small Businesses
  • State Governments
  • Higher Education Inst. (Private)
  • Tribal Governments (Federally Recognized)
  • For Profit Organizations
  • Special District Governments
  • 501(c)(3) Nonprofits
  • Independent School Districts
  • Higher Education Inst. (Public)
  • Public or Indian Housing Auth.
  • Other
Points of contact
Full announcement

Opportunity details come from Grants.gov. Updated .

About this opportunity

The National Institutes of Health is soliciting applications for clinical observational studies in musculoskeletal, rheumatic, and skin diseases under R01 mechanism with a November 2, 2026 application due date; clinical trials are not allowed.

Eligible applicants include higher education institutions (public and private), 501(c)(3) and non-501(c)(3) nonprofits, city and county governments, state governments, tribal governments (federally recognized and other), tribal organizations, special district governments, small businesses, for-profit organizations, independent school districts, public or Indian housing authorities, faith-based or community-based organizations, federally recognized tribal entities, historically black colleges and universities, Hispanic-serving institutions, Alaska Native and Native Hawaiian serving institutions, Asian American Native American Pacific Islander serving institutions, tribally controlled colleges and universities, eligible federal agencies, regional organizations, and U.S. territories or possessions. Non-domestic (non-U.S.) entities are not eligible; however, foreign components of U.S. organizations are allowed.

The funding opportunity was re-issued to incorporate changes from the NIH Simplified Review of Research Project Grant Applications initiative, affecting Section V only. All other aspects remain unchanged from the original announcement.

This opportunity is assigned to CFDA 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, administered by the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The program has awarded $13.85 billion in federal support since 1974 across basic, translational, and clinical investigations in arthritis, musculoskeletal diseases, and skin disorders.

Applicants must use the FORMS-I application guide and follow both general and research-specific instructions provided in the funding opportunity announcement.

Synopsis

This Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same.

Eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Files

File Type Posted
PAR-24-280-Full-Announcement.html HTML file
PKG00289529.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity